Drug Profile
Fosmidomycin
Alternative Names: FR 31564Latest Information Update: 16 May 2007
Price :
$50
*
At a glance
- Originator Jomaa Pharmaka; Justus Liebig University
- Developer Jomaa Pharmaka
- Class Antibacterials; Organophosphorus compounds; Phosphonic acids; Small molecules
- Mechanism of Action Oxidoreductase inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malaria; Urinary tract infections